Stroke Prevention in AFib vs AF Stroke Risk

@Point of Care™ with Ask Cognitive AI is a clinical decision-making mobile platform. Stroke Prevention in Atrial Fibrillation/Venous Thromboembolism @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Ask Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Watson, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Stroke Prevention in Atrial Fibrillation/Venous Thromboembolism @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Stroke Prevention in Atrial Fibrillation/Venous Thromboembolism content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients

"AF Stroke Risk - Atrial Fibrillation Evaluation" is a mobile app designed to help medical practitioner to predict the risk of stroke, transient ischemic attack (TIA), or embolism based on CHA₂DS₂-VASc and CHADS₂ Score. Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, which is associated with a substantial risk of mortality and morbidity from stroke and thromboembolism (TE) event. There are several features of "AF Stroke Risk - Atrial Fibrillation Evaluation", namely: - Simple and very easy to use. - Precise calculation with CHA₂DS₂-VASc and CHADS₂ score. - Determine the risk of atrial fibrillation complication, such as stroke, transient ischemic attack, and embolism. - It is totally free. Download now! The CHA₂DS₂-VASc and CHADS₂ score in "AF Stroke Risk - Atrial Fibrillation Evaluation" are clinical prediction rules for estimating the risk of stroke in patients with non-rheumatic atrial fibrillation (AF), a common and serious heart arrhythmia associated with thromboembolic stroke. Such a score is used to determine whether or not treatment is required with anticoagulant or antiplatelet therapy. This schema could improve the approach to stroke risk stratification in patients with atrial fibrillation (AF) by using "AF Stroke Risk - Atrial Fibrillation Evaluation" app. Disclaimer: all calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "AF Stroke Risk - Atrial Fibrillation Evaluation" app might be different with your local practice. Consult to expert doctor whenever necessary.